TRAVERE THERAPEUTICS INC (TVTX) Forecast, Price Target & Analyst Ratings

NASDAQ:TVTX • US89422G1076

Current stock price

27.25 USD
-0.67 (-2.4%)
At close:
27.34 USD
+0.09 (+0.33%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRAVERE THERAPEUTICS INC (TVTX).

Forecast Snapshot

Consensus Price Target

Price Target
$43.57
+ 59.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
139.52M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.76%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$43.57
Upside
+ 59.88%
From current price of $27.25 to mean target of $43.57, Based on 21 analyst forecasts
Low
$31.31
Median
$43.86
High
$51.45

Price Target Revisions

1 Month
1.53%
3 Months
2.93%

Price Target Summary

21 Wall Street analysts provided a forecast for the next 12 months for TVTX. The average price target is 43.57 USD. This implies a price increase of 59.88% is expected in the next year compared to the current price of 27.25.
The average price target has been revised upward by 2.93% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TVTX Current Analyst RatingTVTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

TVTX Historical Analyst RatingsTVTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
84.76%
TVTX was analyzed by 21 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TVTX.
In the previous month the buy percentage consensus was at a similar level.
TVTX was analyzed by 21 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-25JP MorganMaintains Overweight -> Overweight
2026-02-06Piper SandlerMaintains Neutral -> Neutral
2025-11-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-04Piper SandlerMaintains Neutral -> Neutral
2025-10-31TD CowenMaintains Buy -> Buy
2025-09-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-12StifelMaintains Hold -> Hold
2025-09-11Wells FargoMaintains Overweight -> Overweight
2025-09-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-28HC Wainwright & Co.Maintains Buy -> Buy
2025-08-07ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-08-07WedbushMaintains Outperform -> Outperform
2025-06-11CitigroupMaintains Buy -> Buy
2025-05-16WedbushReiterate Outperform -> Outperform
2025-05-02StifelMaintains Hold -> Hold
2025-05-02WedbushReiterate Outperform -> Outperform
2025-04-23Cantor FitzgeraldReiterate Overweight -> Overweight
2025-04-14GuggenheimReiterate Buy -> Buy
2025-04-10Canaccord GenuityMaintains Buy -> Buy
2025-04-03Cantor FitzgeraldReiterate Overweight -> Overweight
2025-04-01B of A SecuritiesMaintains Buy -> Buy
2025-02-26JP MorganMaintains Overweight -> Overweight
2025-02-24CitigroupMaintains Buy -> Buy
2025-02-21Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.20
Revenue Estimate
139.52M
Revenue Q2Q
70.70%
EPS Q2Q
56.84%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
2.45%
Revenue (3 Months)
2.45%
EPS (1 Month)
-48.10%
EPS (3 Months)
-48.10%

Next Earnings Summary

TVTX is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -0.2 USD and the consensus revenue estimate is 139.52M USD.
The next earnings revenue estimate has been revised upward by 2.45% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TVTX revenue by date.TVTX revenue by date.
145.238M
-31.49%		233.175M
60.55%		490.728M
110.45%		709.71M
44.62%		935.11M
31.76%		1.104B
18.06%		1.338B
21.20%		1.549B
15.77%		1.856B
19.82%		2.073B
11.69%		1.979B
-4.53%
EBITDA
YoY % growth
TVTX ebitda by date.TVTX ebitda by date.
-338.214M
-44.90%		-212.629M
37.13%		-2.081M
99.02%		147.68M
7,196.59%		437.64M
196.34%		612.32M
39.91%		786.74M
28.49%		1.158B
47.19%		1.134B
-2.07%		1.301B
14.73%		N/A
EBIT
YoY % growth
TVTX ebit by date.TVTX ebit by date.
-376.744M
-41.37%		-256.184M
32.00%		-62.824M
75.48%		52.22M
183.12%		174.81M
234.76%		365.96M
109.35%		505.74M
38.20%		666.01M
31.69%		788.76M
18.43%		901.17M
14.25%		1.048B
16.29%
Operating Margin
TVTX operating margin by date.TVTX operating margin by date.
-259.40%-109.87%-12.80%7.36%18.69%33.15%37.80%43.00%42.50%43.47%52.96%
EPS
YoY % growth
TVTX eps by date.TVTX eps by date.
-4.60
-5.26%		-4.10
10.87%		-0.30
92.68%		0.29
195.54%		2.06
617.68%		2.45
19.17%		7.03
186.69%		8.79
25.11%		11.30
28.58%		12.58
11.28%		11.90
-5.42%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.20
56.84%		-0.08
43.01%		0.14
-48.48%		0.59
1,876.86%
Revenue
Q2Q % growth		139.52M
70.70%		159.66M
39.50%		173.47M
5.22%		236.37M
82.26%
EBITDA
Q2Q % growth		9.144M
130.61%		42.03M
196.65%		89.856M
33.05%		100.63M
255.39%
EBIT
Q2Q % growth		-12.516M
70.67%		2.428M
119.19%		11.84M
-52.51%		67.179M
307.16%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TVTX Yearly Revenue VS EstimatesTVTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
TVTX Yearly EPS VS EstimatesTVTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
116.67%
EPS Next 5 Year
99.13%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
29.11%
Revenue Next 5 Year
24.73%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
159.80%
EBIT Next 5 Year
99.22%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TRAVERE THERAPEUTICS INC / TVTX Forecast FAQ

What is the price target for TVTX stock?

21 analysts have analysed TVTX and the average price target is 43.57 USD. This implies a price increase of 59.88% is expected in the next year compared to the current price of 27.25.

What is the next earnings date for TVTX stock?

TRAVERE THERAPEUTICS INC (TVTX) will report earnings on 2026-04-29.

What are the consensus estimates for TRAVERE THERAPEUTICS INC (TVTX) next earnings?

The consensus EPS estimate for the next earnings of TRAVERE THERAPEUTICS INC (TVTX) is -0.2 USD and the consensus revenue estimate is 139.52M USD.

What is the consensus rating for TRAVERE THERAPEUTICS INC (TVTX) stock?

The consensus rating for TRAVERE THERAPEUTICS INC (TVTX) is 84.7619 / 100 . This indicates that analysts generally have a positive outlook on the stock.